Why the study?
Hypertension remains a leading global cause of cardiovascular mortality and morbidity despite effective medications, with shifting blood pressure targets, evolving measurement methods, and persistent challenges with under- and overtreatment.
Key points are not available for this paper at this time.
Design
Review
This review highlights recent advances in hypertension management, emphasizing the shift towards lower blood pressure targets, the importance of out-of-office measurements, and the development of novel pharmacological and interventional therapies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Leontsinis et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: